ArticleOncotarget2015

Basal and therapy-driven hypoxia-inducible factor-1α confers resistance to endocrine therapy in estrogen receptor-positive breast cancer.

Xiaoqing Jia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.